Presentation is loading. Please wait.

Presentation is loading. Please wait.

Fig 1 The CONSORT participant flow diagram for primary endpoints.

Published byGillian Haynes Modified over 6 years ago

Similar presentations

Presentation on theme: "Fig 1 The CONSORT participant flow diagram for primary endpoints."— Presentation transcript:

1 Fig 1 The CONSORT participant flow diagram for primary endpoints.
From: Effect of supervised aerobic exercise rehabilitation on physical fitness and quality-of-life in survivors of critical illness: an exploratory minimized controlled trial (PIX study) Br J Anaesth. 2014;113(1): doi: /bja/aeu051 Br J Anaesth | © The Author [2014]. Published by Oxford University Press on behalf of the British Journal of Anaesthesia.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact

Download ppt "Fig 1 The CONSORT participant flow diagram for primary endpoints."

Similar presentations

Fig 1 Difficult Airway Society difficult intubation guidelines: overview. Difficult Airway Society, 2015, by permission of the Difficult Airway Society.

Fig 1 Difficult Airway Society difficult intubation guidelines: overview. Difficult Airway Society, 2015, by permission of the Difficult Airway Society.
Fig. 4. Carer ratings of executive functioning (Dysexecutive Questionnaire) and memory (Memory Checklist) in the 3 groups at the beginning and end of the.

Fig. 4. Carer ratings of executive functioning (Dysexecutive Questionnaire) and memory (Memory Checklist) in the 3 groups at the beginning and end of the.
Fig. 1 Frames of bees (mean ± SE) for CN, Russian honey bee, and colonies with the VSH trait for selected months for separate trials in 2010–2011 and 2011–2012.

Fig. 1 Frames of bees (mean ± SE) for CN, Russian honey bee, and colonies with the VSH trait for selected months for separate trials in 2010–2011 and 2011–2012.
Table 1 Patient characteristics of attendees of the influenza vaccination, irrespective of AF status From: Yield of screening for atrial fibrillation in.

Table 1 Patient characteristics of attendees of the influenza vaccination, irrespective of AF status From: Yield of screening for atrial fibrillation in.
FIGURE 4: Mean change from baseline in iPTH concentration during treatment and 60 days after treatment withdrawal. Data are shown as the mean change ±

FIGURE 4: Mean change from baseline in iPTH concentration during treatment and 60 days after treatment withdrawal. Data are shown as the mean change ±
Fig. 1. Significant clusters in the amygdala and dlPFC, four-way interaction effect (group by valence by temperature by time), small volume corrected.

Fig. 1. Significant clusters in the amygdala and dlPFC, four-way interaction effect (group by valence by temperature by time), small volume corrected.
From: Dynamic De/Centralization in Canada, 1867–2010

From: Dynamic De/Centralization in Canada, 1867–2010
Figure 3: (a and b) Preoperative contrast-eCT

Figure 3: (a and b) Preoperative contrast-eCT
Figure 1. Unified models predicting gene regulation based on landscapes of gene-regulating factors. For each gene, position specific combinatorial patterns.

Figure 1. Unified models predicting gene regulation based on landscapes of gene-regulating factors. For each gene, position specific combinatorial patterns.
Fig. 8 The two cases for the terminal edge e<sub>0</sub>

Fig. 8 The two cases for the terminal edge e<sub>0</sub>
Figure 1 Proportion of criteria chosen (as percentages, grouped into issues). From: Developing national obesity policy in middle-income countries: a case.

Figure 1 Proportion of criteria chosen (as percentages, grouped into issues). From: Developing national obesity policy in middle-income countries: a case.
J Exp Bot. 2017;68(17): doi: /jxb/erx352

J Exp Bot. 2017;68(17): doi: /jxb/erx352
Figure 2. Chronic kidney disease risk tool application.

Figure 2. Chronic kidney disease risk tool application.
Fig. 1. Scheme for classifying renal function without access to laboratory test results. *Renal-specific drugs: phosphate binders (ATC codes.

Fig. 1. Scheme for classifying renal function without access to laboratory test results. *Renal-specific drugs: phosphate binders (ATC codes.
Figure 1 Study flow chart.

Figure 1 Study flow chart.
From: Rethinking the Effects of Financial Globalization *

From: Rethinking the Effects of Financial Globalization *
Figure 5: Three-dimensional reconstruction of the CT scan showing the trapped air in the head and neck region. From: Distinct subcutaneous emphysema following.

Figure 5: Three-dimensional reconstruction of the CT scan showing the trapped air in the head and neck region. From: Distinct subcutaneous emphysema following.
From: Learning by Working in Big Cities

From: Learning by Working in Big Cities
From: THE FALLACIES OF PATENT-HOLDUP THEORY

From: THE FALLACIES OF PATENT-HOLDUP THEORY
Fig. 1. Trial structure for the experimental task.

Fig. 1. Trial structure for the experimental task.

Similar presentations

Ads by Google